Foresight Diagnostics and Partners to Present New Data on Ultra-sensitive Minimal Residual Disease Detection and Clinical Trial Progress at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

May 1, 2025 UCBN News, Syndication Comments Off on Foresight Diagnostics and Partners to Present New Data on Ultra-sensitive Minimal Residual Disease Detection and Clinical Trial Progress at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

BOULDER, Colo., May 1, 2025 /PRNewswire/ — Foresight Diagnostics, Inc. (“Foresight”), a leading diagnostics company specializing in the development of ultra-sensitive minimal residual disease (MRD) detection, today announced that new data in newly diagnosed diffuse large B-cell lymphoma…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks

Related Articles

No Picture
News

Dr. Steven Ojemann completed the 10th Annual Stereotactic and Functional Hands on Course November 3-5, 2023

November 7, 2023 UCBN News, Syndication Comments Off on Dr. Steven Ojemann completed the 10th Annual Stereotactic and Functional Hands on Course November 3-5, 2023

This 3-day course is conducted by internationally known neurosurgery faculty who address a variety of neuromodulation and ablative techniques, stereotactic planning, and execution of stereotactic principles. The hands-on workshop sessions include instruction on correctly attaching […]

No Picture
News

Havah Therapeutics Announces the Filing of a Patent Application Relating to the Use of HAV-088 for Reducing Tumor Size and Conserving Breast Tissue

March 27, 2025 UCBN News, Syndication Comments Off on Havah Therapeutics Announces the Filing of a Patent Application Relating to the Use of HAV-088 for Reducing Tumor Size and Conserving Breast Tissue

BOULDER, Colo.–(BUSINESS WIRE)–Havah Therapeutics, a clinical stage biopharmaceutical company developing innovative therapies for prevention and treatment of breast cancers, announces the filing of a new provisional patent application directed to the use of HAV-088 for […]